top of page




Jonathan Poyer
9h3 min read


Jonathan Poyer
13h3 min read


Jonathan Poyer
13h2 min read


Jonathan Poyer
6d2 min read


Jonathan Poyer
Nov 52 min read


Jonathan Poyer
Oct 302 min read


Jonathan Poyer
Oct 294 min read


Jonathan Poyer
Oct 272 min read


Amgen & AstraZeneca: Nearly 69% Achieve Remission in Phase 3 — But What Does That Mean for Patients?
Jonathan Poyer
Oct 224 min read


Jonathan Poyer
Oct 223 min read


Jonathan Poyer
Oct 92 min read


Jonathan Poyer
Oct 22 min read
bottom of page